α-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell...

Area of Science:

• Neuroscience
• Cell Biology
• Pathology

Background:

• Cerebral endothelial dysfunction is observed in neurodegenerative disorders like Alzheimer's, Huntington's, and Parkinson's diseases.
• Alpha-synuclein (α-synuclein) aggregation is a key feature of Parkinson's disease, but its direct impact on endothelial function is not well understood.

Purpose of the Study:

• To investigate the effect of preformed α-synuclein fibrils on endothelial function in vitro.
• To examine the expression of tight junction proteins in response to α-synuclein neurotoxicity.

Main Methods:

• Utilized a well-established endothelial cell model to study the effects of α-synuclein fibrils.
• Analyzed the expression of tight junction proteins (zona occludens-1 and occludin) in vitro.
• Examined postmortem brain tissue from Parkinson's disease patients.

Main Results:

• Exposure to α-synuclein fibrils significantly perturbed the expression of tight junction proteins, including zona occludens-1 and occludin, in endothelial cells.
• Disrupted expression of these tight junction proteins was also observed in postmortem brains of Parkinson's disease patients.
• Limited evidence of functional impairment (transendothelial electrical resistance, permeability) was found in vitro.

Conclusions:

• Misfolded α-synuclein can interact with and affect the cerebral endothelial system.
• The study demonstrates a novel link between α-synuclein pathology and endothelial cells.
• The precise role of these endothelial changes in the pathogenesis of Parkinson's disease requires further elucidation.